The development of a comparison approach for illumina bead chips unravels unexpected challenges applying newest generation microarrays

4Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

Abstract

BACKGROUND: The MAQC project demonstrated that microarrays with comparable content show inter- and intra-platform reproducibility. However, since the content of gene databases still increases, the development of new generations of microarrays covering new content is mandatory. To better understand the potential challenges updated microarray content might pose on clinical and biological projects we developed a methodology consisting of in silico analyses combined with performance analysis using real biological samples. RESULTS: Here we clearly demonstrate that not only oligonucleotide design but also database content and annotation strongly influence comparability and performance of subsequent generations of microarrays. Additionally, using human blood samples and purified T lymphocyte subsets as two independent examples, we show that a performance analysis using biological samples is crucial for the assessment of consistency and differences. CONCLUSION: This study provides an important resource assisting investigators in comparing microarrays of updated content especially when working in a clinical or regulatory setting.

Cite

CITATION STYLE

APA

Eggle, D., Debey-Pascher, S., Beyer, M., & Schultze, J. L. (2009). The development of a comparison approach for illumina bead chips unravels unexpected challenges applying newest generation microarrays. BMC Bioinformatics, 10. https://doi.org/10.1186/1471-2105-10-186

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free